376 related articles for article (PubMed ID: 19885812)
41. Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues.
Wolin EM; Jarzab B; Eriksson B; Walter T; Toumpanakis C; Morse MA; Tomassetti P; Weber MM; Fogelman DR; Ramage J; Poon D; Gadbaw B; Li J; Pasieka JL; Mahamat A; Swahn F; Newell-Price J; Mansoor W; Öberg K
Drug Des Devel Ther; 2015; 9():5075-86. PubMed ID: 26366058
[TBL] [Abstract][Full Text] [Related]
42. Atypical metastatic carcinoid of the uterine cervix and review of the literature.
Yoshida Y; Sato K; Katayama K; Yamaguchi A; Imamura Y; Kotsuji F
J Obstet Gynaecol Res; 2011 Jun; 37(6):636-40. PubMed ID: 21375671
[TBL] [Abstract][Full Text] [Related]
43. [Bronchopulmonary carcinoid tumours].
Rena O; Filosso PL; Ruffini E; Oliaro A
Minerva Chir; 2002 Aug; 57(4):403-23. PubMed ID: 12145571
[TBL] [Abstract][Full Text] [Related]
44. [A case of multiple liver metastasis from ileac carcinoid effectively treated with continuous intraarterial infusion of somatostatin analog].
Wadamori K; Oka M; Shimizu R; Tangoku A; Hazama S; Yagyu T; Suzuki T; Hatano S; Kurokawa F; Okita K
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1669-72. PubMed ID: 7574789
[TBL] [Abstract][Full Text] [Related]
45. Multimodality treatment for gastric carcinoid tumor with liver metastases.
Caplin ME; Hodgson HJ; Dhillon AP; Begent R; Buscombe J; Dick R; Rolles K; Burroughs AK
Am J Gastroenterol; 1998 Oct; 93(10):1945-8. PubMed ID: 9772061
[TBL] [Abstract][Full Text] [Related]
46. Metastatic thymic carcinoid responds to chemoradiation and octreotide: A case report.
Mei Z; Wang H; Ren S; Wei J; Gu Y
Medicine (Baltimore); 2018 Nov; 97(47):e13286. PubMed ID: 30461637
[TBL] [Abstract][Full Text] [Related]
47. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
Caplin ME; Baudin E; Ferolla P; Filosso P; Garcia-Yuste M; Lim E; Oberg K; Pelosi G; Perren A; Rossi RE; Travis WD;
Ann Oncol; 2015 Aug; 26(8):1604-20. PubMed ID: 25646366
[TBL] [Abstract][Full Text] [Related]
48. The importance of follow-up examinations in patients with carcinoid tumor.
Szilvás A; Székely G; Szilvási I; Sági S; Jakab F
Hepatogastroenterology; 2003; 50(53):1452-3. PubMed ID: 14571761
[TBL] [Abstract][Full Text] [Related]
49. Goblet cell carcinoid tumors (adenocarcinoid) of the appendix.
Toumpanakis C; Standish RA; Baishnab E; Winslet MC; Caplin ME
Dis Colon Rectum; 2007 Mar; 50(3):315-22. PubMed ID: 17195086
[TBL] [Abstract][Full Text] [Related]
50. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases.
Burke AP; Thomas RM; Elsayed AM; Sobin LH
Cancer; 1997 Mar; 79(6):1086-93. PubMed ID: 9070484
[TBL] [Abstract][Full Text] [Related]
51. Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors.
Schell SR; Camp ER; Caridi JG; Hawkins IF
J Gastrointest Surg; 2002; 6(5):664-70. PubMed ID: 12399054
[TBL] [Abstract][Full Text] [Related]
52. Carcinoid tumor regression with high-dose octreotide acetate: a patient report.
Lokich J
Am J Clin Oncol; 1998 Jun; 21(3):246-7. PubMed ID: 9626790
[TBL] [Abstract][Full Text] [Related]
53. Midgut carcinoid tumours: surgical treatment and prognosis.
Kerström G; Hellman P; Hessman O
Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):717-28. PubMed ID: 16253896
[TBL] [Abstract][Full Text] [Related]
54. Management of midgut carcinoids.
Akerström G; Hellman P; Hessman O; Osmak L
J Surg Oncol; 2005 Mar; 89(3):161-9. PubMed ID: 15719373
[TBL] [Abstract][Full Text] [Related]
55. Flush symptoms caused by a mesenteric carcinoid without liver metastases.
Sonnet S; Wiesner W
JBR-BTR; 2002; 85(5):254-6. PubMed ID: 12463502
[TBL] [Abstract][Full Text] [Related]
56. [Intestinal carcinoid tumour: Case report].
Mussan-Chelminsky G; Vidal-González P; Núñez-García E; Valencia-García LC; Márquez-Ugalde MÁ
Cir Cir; 2015; 83(5):438-41. PubMed ID: 26319938
[TBL] [Abstract][Full Text] [Related]
57. AACE/ACE disease state clinical review: diagnosis and management of midgut carcinoids.
Liu EH; Solorzano CC; Katznelson L; Vinik AI; Wong R; Randolph G
Endocr Pract; 2015 May; 21(5):534-545. PubMed ID: 25962092
[TBL] [Abstract][Full Text] [Related]
58. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients.
Ruszniewski P; Rougier P; Roche A; Legmann P; Sibert A; Hochlaf S; Ychou M; Mignon M
Cancer; 1993 Apr; 71(8):2624-30. PubMed ID: 8384072
[TBL] [Abstract][Full Text] [Related]
59. Primary hepatic carcinoid tumor with carcinoid syndrome and carcinoid heart disease: a case report of a patient on long-term follow-up.
Tohyama T; Matsui K; Kitagawa K
Intern Med; 2005 Sep; 44(9):958-62. PubMed ID: 16258211
[TBL] [Abstract][Full Text] [Related]
60. Ileal carcinoid tumor with liver metastases and cardiac involvement treated with intraarterial liposomal doxorubicin and valve replacement.
González Cao M; Bastarrika G; García-Foncillas J; Aristu J; Chopitea A; Martín Algarra S
Clin Transl Oncol; 2006 May; 8(5):369-71. PubMed ID: 16760013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
